The head of Pfizer, one of the drugmakers racing to develop a coronavirus vaccine, says the Covid-19 vaccine trial won't be rushed by political pressure.
During Tuesday's debate with former Vice President Joe Biden, Trump said he had talked with the companies whose experimental vaccines are furthest along in testing.
“I’ve spoken to Pfizer, I’ve spoken to all of the people that you have to speak to, Moderna, Johnson & Johnson, and others. They can go faster than that by a lot,” Trump claimed. “It’s become very political.”Pfizer has said that it expects to have data from its ongoing late-stage test by October that could show whether the vaccine is safe and effective. In his letter to employees, Bourla wrote that the company hopes to have “a hundred million doses delivered by the end of the year.
Those doses could not be distributed until the Food and Drug Administration reviews Pfizer’s data and decides whether to issue what’s called an emergency use authorization. That would allow distribution of the vaccine on a limited basis, with initial shots expected to go to medical and other frontline workers, nursing homes and people most at risk of catching or becoming seriously ill from the virus.
Moderna’s chief executive, Stéphane Bancel, told the UK’s Financial Times on Wednesday that Moderna would not be ready to seek emergency use authorization from the FDA for its vaccine candidate before Nov. 25 at the earliest.And AstraZeneca, which has a candidate in late-stage trials around the world, has its U.S. study on hold while the FDA reviews a possible safety problem.
Bourla and top executives of eight other companies developing COVID-19 vaccines and treatments pledged in early September not to seek even emergency use authorization, let alone a full approval of their products, until they were proven safe and effective.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer CEO: ‘Disappointed’ in presidential debate, vows no political pressure on Covid shotThe CEO of Pfizer — one of the frontrunners in the coronavirus vaccine race — said in a staff memo Thursday that the company wouldn’t cave to political pressure to rush its vaccine to market, while at the same time decrying 'those who argue for delay'
Weiterlesen »
Covid-19 Vaccine’s Development Won’t Be Affected by Politics, Pfizer CEO SaysPfizer’s chief executive sought to assure the drugmaker’s employees that their experimental Covid-19 vaccine wouldn’t be influenced by politics, two days after President Trump mentioned the company during the debate.
Weiterlesen »
CureVac plans global late-stage COVID-19 vaccine trial in fourth quarterGermany's CureVac NV said on Tuesday it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers in the fourth quarter.
Weiterlesen »
We Need One Million More Volunteers for the COVID-19 Vaccine TrialsIn order to have effective vaccine trials, America needs another one million volunteers to sign up, especially from diverse backgrounds.
Weiterlesen »
Kids should be in school, not six-hour COVID test lineups'As we walked away from the school yard, I heard a loud sniff to my right. Then another one. My heart jumped into my throat. Shit. We have a runny nose.'
Weiterlesen »
In Appalachia, people watch COVID-19, race issues from afarWith the country torn and crises piling up, the feeling of isolation in the small towns of southeast Ohio is more acute than ever. An AP team on a road trip across America sees how faith in government in the Appalachian foothills has turned to distrust.
Weiterlesen »